BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®
Source:
Nasdaq GlobeNewswire
/
03 Nov 2023 11:00:00 America/Chicago
N/A
Share on,